title: NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia.
authors.forename: J
authors.initials: J
authors.lastname: Karle
authors.forename: L
authors.initials: L
authors.lastname: Clemmesen
authors.forename: L
authors.initials: L
authors.lastname: Hansen
authors.forename: M
authors.initials: M
authors.lastname: Andersen
authors.forename: J
authors.initials: J
authors.lastname: Andersen
authors.forename: C
authors.initials: C
authors.lastname: Fensbo
authors.forename: M
authors.initials: M
authors.lastname: Sloth-Nielsen
authors.forename: B K
authors.initials: BK
authors.lastname: Skrumsager
authors.forename: H
authors.initials: H
authors.lastname: Lublin
authors.forename: J
authors.initials: J
authors.lastname: Gerlach
mesh_terms: D000328:Adult; D001552:Benzazepines / Q000009:adverse effects* / Q000627:therapeutic use*; D001572:Benzofurans / Q000009:adverse effects* / Q000627:therapeutic use*; D018492:Dopamine Antagonists / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D015990:Placebo Effect; D017447:Receptors, Dopamine D1 / Q000037:antagonists & inhibitors*; D012559:Schizophrenia / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D001552:Benzazepines; D001572:Benzofurans; D018492:Dopamine Antagonists; D017447:Receptors, Dopamine D1; C077122:5-(2,3-dihydrobenzofuran-7-yl)-3-methyl-8-nitro-2,3,4,5-tetrahydro-1H-3-benzazepin-7-ol